ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,963.73
-0.36%
US Tech 100
20,436.40
-0.26%
Dow Jones
43,816.13
-0.32%
Brent Oil
72.135
0.38%
Bitcoin
88,982.26
-1.75%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Entero Therapeutics Inc (ENTO) Quote

Entero Therapeutics Inc

Entero Therapeutics Inc (ENTO)

NASDAQ
0.4852
-0.1448
( -22.98% )
Updated: 12:11:03
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.4852
Bid
0.4849
Ask
0.4999
Volume
443,107
0.4249 Day's Range 0.615
0.185 52 Week Range 3.16
Previous Close
0.63
Open
0.615
Last Trade
100
@
0.4852
Last Trade Time
12:10:38
Average Volume (3m)
423,051
Financial Volume
$ 209,973
VWAP
0.473866

Ask ADVFN Intelligence (AI)

ENTO Latest News

More News

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum

BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

4 hours ago
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 13 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 13 2024
Edgar (US Regulatory)

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Proposed merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing (i) Journey’s next-gen, first-in-class ADC-rivalling, nano-immunoconjugates (“NIC”) platform...

November 13 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

October 21 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

October 10 2024
Edgar (US Regulatory)

Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings

BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

September 10 2024
GlobeNewswire Inc.

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

August 23 2024
GlobeNewswire Inc.

Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program

BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

July 31 2024
GlobeNewswire Inc.

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and treatment efficacy Special editorial highlights the...

June 27 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2148-30.68571428570.70.7161990.42494062570.63105266CS
4-0.0498-9.308411214950.5350.86550.42492794080.66557704CS
120.065215.52380952380.420.86550.284230510.56034707CS
26-2.4748-83.60810810812.963.160.1854805680.47720261CS
52-2.4748-83.60810810812.963.160.1854805680.47720261CS
156-2.4748-83.60810810812.963.160.1854805680.47720261CS
260-2.4748-83.60810810812.963.160.1854805680.47720261CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MTEMMolecular Templates Inc
$ 0.759117
(135.68%)
213.26M
GORVLazydays Holdings Inc
$ 1.57
(70.65%)
3.16M
OMEROmeros Corporation
$ 6.44
(53.70%)
10.98M
AGFYAgrify Corporation
$ 15.20
(45.73%)
557.58k
QUBTQuantum Computing Inc
$ 3.775
(41.92%)
138.03M
SOWGSow Good Inc
$ 4.54
(-53.72%)
1.54M
NVCTNuvectis Pharma Inc
$ 6.3297
(-40.68%)
1.32M
TRNRInteractive Strength Inc
$ 3.7327
(-35.97%)
1.1M
OPRXOptimizeRx Corporation
$ 4.12
(-33.01%)
1.21M
JTAIJet AI Inc
$ 5.62
(-30.79%)
312.64k
ELABElevai Labs Inc
$ 0.027699
(12.14%)
1.51B
XTIAXTI Aerospace Inc
$ 0.0633
(10.66%)
313.86M
MTEMMolecular Templates Inc
$ 0.751725
(133.38%)
213.5M
SVMHSRIVARU Holding Ltd
$ 0.0274
(13.22%)
211.03M
QUBTQuantum Computing Inc
$ 3.77
(41.73%)
138.05M

ENTO Discussion

View Posts
glenn1919 glenn1919 20 hours ago
ENTO........................https://stockcharts.com/h-sc/ui?s=ENTO&p=W&b=5&g=0&id=p86431144783
👍️0
conix conix 1 month ago
ENTO Chart

👍️0
glenn1919 glenn1919 2 months ago
ENTO..............................................https://stockcharts.com/h-sc/ui?s=ENTO&p=W&b=5&g=0&id=p86431144783
👍️0
gail gail 3 months ago
not in now but….

…

i see it went up some.

i grabbed some gcts. watch that one.
👍️0
TheFinalCD TheFinalCD 3 months ago
ENTO hit .33 where did you buy

I follow this youngster for BK plays

$ENTO sooo NOBODY is on this $700k market cap BK play except for me? 🤔🤔

The company just announced they have DEFAULTED on their credit agreement, which will ADVERSELY AFFECT their business🚨🗞️

No delisting date in sight either so Ill be waiting for the BK pump on this one… pic.twitter.com/5CwGB9LUAn— The Bankruptcy King 👑 (@TyroneLopez_) August 12, 2024
👍️0
gail gail 3 months ago
hey glen, i assume you made this page? thx.
👍️0
gail gail 3 months ago
Im glad someone made a….

…

board for this one. i couldnt figure out how to do it.

grabbed some on the dip today. let’s do this! well, i say “let’s” but no one else is here, lol
👍️0
glenn1919 glenn1919 3 months ago
ENTO........................................https://stockcharts.com/h-sc/ui?s=ENTO&p=W&b=5&g=0&id=p86431144783
👍️0

Your Recent History

NASDAQ
ENTO
Entero Therapeutics
USOTC
IGXT
IntelGenx Technologies (CE)
NYSE
TYG
Tortoise Energy Infrastr...
TSXV
ARL
Aurum Lake Mining
BIT
UC7T6K
Unicredit Bank
NASDAQ
SIFY
Sify Technologies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved